Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label, Parallel-Group Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants
Conditions
Interventions
Tirabrutinib
Locations
3
United States
Arizona Liver Health
Chandler, Arizona, United States
Panax Clinical Research
Miami Lakes, Florida, United States
Orlando Clinical Research Center, Inc.
Orlando, Florida, United States
Start Date
October 1, 2025
Primary Completion Date
April 9, 2026
Completion Date
December 31, 2026
Last Updated
April 16, 2026
NCT07074470
NCT04688151
NCT06714370
NCT04253496
NCT00710151
Lead Sponsor
Ono Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions